Screener
Regenxbio RGNX Total Revenue
Total Revenue at other companies
Segments
By product
Other financials
Where this comes from
Reported directly by Regenxbio in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Regenxbio’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 7:15 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336725
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Revenues | ||||
| License and royalty revenue | $103,841 | $18,465 | $108,931 | $105,514 |
| Service revenue | 4,178 | 2,894 | 5,481 | 4,857 |
| Total revenues | 108,019 | 21,359 | 114,412 | 110,371 |
| Operating Expenses | ||||
| Cost of license and royalty revenues | 1,042 | 5,209 | 12,116 | 8,645 |
| Research and development | 56,086 | 59,500 | 113,425 | 112,587 |
| General and administrative | 21,616 | 19,883 | 42,922 | 40,230 |
Item 1. Financial Statements.
FAQ
- What is Regenxbio's total revenue?
- Regenxbio (RGNX) reported total revenue of $108.02M in Q2 2026.
- How has Regenxbio's total revenue changed year-over-year?
- Regenxbio's total revenue increased by 405.7% year-over-year, from $21.36M to $108.02M.
- What is the long-term trend for Regenxbio's total revenue?
- Over 4 years (2021 to 2025), Regenxbio's total revenue has grown at a -22.4% compound annual growth rate (CAGR), from $470.35M to $170.44M.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.
Ask your AI about Regenxbio's total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude